Protection from acute and chronic lung diseases by curcumin

Advances in Experimental Medicine and Biology

Volumn 595, Issue , 2007, Pages 379-405

  Venkatesan, Narayanan ^a   Punithavathi, Durairaj ^b   Babu, Mary ^b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; AZATHIOPRINE; BLEOMYCIN; CIGARETTE SMOKE; COLCHICINE; CORTICOSTEROID; CURCUMIN; CYCLOPHOSPHAMIDE; FISH OIL; GAMMA INTERFERON; KETOCONAZOLE; LISOFYLLINE; NICOTINE; NITRIC OXIDE; PARAQUAT; PENICILLAMINE; PIRFENIDONE; PROSTACYCLIN; PROSTAGLANDIN; SURFACTANT;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIR POLLUTANT; AIRBORNE PARTICLE; ALLERGIC ASTHMA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CURCUMA LONGA; CYTOKINE PRODUCTION; DUST; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; HUMAN; LUNG DISEASE; LUNG FIBROSIS; LUNG TOXICITY; LUNG TRANSPLANTATION; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION PNEUMONIA; RESPIRATORY TRACT ALLERGY; REVIEW; SCLERODERMA; SEPTIC SHOCK; VIRUS PNEUMONIA;

EID: 84934444397     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-46401-5_17     Document Type: Review

References (71)

1. B. B. Aggarwal and S. Shishodia, Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals, Reasoning for seasoning. Ann NY Acad Sci 1030, 434 (2004).
2. S. Shishodia, S. Gautam, and B. B. Aggarwal, Curcumin: Getting back to the roots. Ann NY Acad Sci 1056, 206 (2005).
3. K. C. Thresiamma, J. George, and R. Kuttan, Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 34, 845 (1996).
4. N. Venkatesan, Pulmonary protective effects of curcumin against paraquat toxicity Life Sci 66, PL21 (2000).
5. N. Venkatesan and G. Chandrakasan, Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142, 79 (1995).
6. N. Venkatesan, V. Punithavathi, and G. Chandrakasan, Curcumin protects bleomycin-induced lung injury in rats, Life Sci 61, PL51 (1997).
7. D. Punithavathi, N. Venkatesan, and M. Babu, Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 131, 169 (2000).
8. D. Punithavathi, N. Venkatesan, and M. Babu, Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 139, 1342 (2003).
9. C. Kalpana and V. P. Menon, Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity. Pol J Pharmacol 56, 581 (2004).
10. B. Madan and B. Ghosh, Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock. Shock 19, 91 (2003).
11. A. Ram, M. Das, and B. Ghosh, Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 26, 1021 (2003).
12. T. J. Gross and G. W. Hunninghake, Idiopathic pulmonary fibrosis. N Engl J Med 345, 517 (2001).
13. P. Camus, A. Fanton, P. Bonniaud, C. Camus, and P. Foucher, Interstitial lung disease induced by drugs and radiation. Respiration. 71, 301 (2004).
14. J. A. Copper, Jr. Drug-induced lung disease. Adv Intern Med 42, 231 (1977).
15. E. Crouch, Pathobiology of pulmonary fibrosis. Am J Physiol 259, L159 (1990).
16. M. P. Keane, R. M. Strieter, and J. A. Belperio, Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol 25, 429 (2005).
17. M. Gharaee-Kermani and S. H. Phan, Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Des 11, 3943 (2005).
18. D. Bouros and K. M. Antoniou, Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 26, 693 (2005).
19. R. C. Chambers and G. J. Laurent, Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 30, 194 (2002).
20. N. Hashimoto, H. Jin, T. Liu, S. W. Chensue, and S. H. Phan, Bone marrow-derived progenitor cells in pulmonary fibrosis J Clin Invest 113(2), 243-252 (2004).
21. K K. Soudamini, M. C. Unnikrishnan, K. B. Soni, and R. Kuttan, Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol 36, 239 (1992).
22. W. H. Chung, B. M. Bennett, W. J. Racz, J. F. Brien, and T. E. Massey, Induction of c-jun and TGF-β1in Fischer 344 rats during amiodarone-induced pulmonary fibrosis, Am J Physiol 281, L1180 (2001).
23. C. P. Denton and C. M. Black, Targeted therapy comes of age in scleroderma. Trends Immunol 26, 596 (2005).
24. E. Tourkina, P. Gooz, J. C. Oates, A. Ludwicka-Bradley, R. M. Silver, and S. Hoffman, Curcumin-induced apoptosis in scleroderma lung fibroblasts, role of protein kinase cepsilon. Am J Respir Cell Mol Biol 31, 28 (2004).
25. R. M. Senior and S. D. Shapiro, Chronic obstructive pulmonary disease: Epidemiology, pathophysiology, and pathogenesis. In: Fishman's Pulmonary Diseases and Disorders. Volume 1, A. P. Fishman et al., eds. New York: McGraw-Hill, 1998, pp. 659-681.
26. P. M. O'Byrne and D. S. Postma, The many faces of airway inflammation: Asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 15, S41 (1999).
27. J. R. Spurzem and S. I. Rennard, Pathogenesis of COPD. Semin Respir Crit Care Med 26, 142 (2005).
28. M. Saetta, Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 147, 301 (1993).
29. M. Saetta, CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160, 711 (1999).
30. J. L. Wright and A. Churg, Animal models of cigarette smoke-induced COPD. Chest 122, 301S (2002).
31. V. L. Kinnula, Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60, 693 (2004).
32. W. Boots, G. R. Haenen, and A. Bast, Oxidant metabolism in chronic obstructive pulmonary disease Eur Respir J 46(Suppl),14 (2003).
33. P. J. Barnes, COPD: Is there light at the end of the tunnel? Curr Opin Pharmacol 4, 263 (2004).
34. C. Kalpana and V. P. Menon, Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem 53, 82 (2004).
35. S. Shishodia, P. Potdar, C. G. Gairola, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269 (2003).
36. M. A. Matthay and G. A. Zimmerman, Acute lung injury and the acute respiratory distress syndrome: Four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33, 319 (2005).
37. M. A. Schwarz, Acute lung injury: cellular mechanisms and derangements. Paediatr Respir Rev 2, 3 (2001).
38. G. J. Bellingan, The pulmonary physician in critical care: The pathogenesis of ALI/ARDS. Thorax 57, 540 (2002).
39. R. Jain and A. DalNogare, Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc 81, 205 (2006).
40. N. R. MacIntyre, Current issues in mechanical ventilation for respiratory failure. Chest 128, 561S (2005).
41. H. Freise, U. B. Bruckner, and H. U. Spiegel, Animal models of sepsis. J Invest Surg 14, 195 (2003)
42. C. W. Chow, M. T. Herrera Abreu, T. Suzuki, and G. P. Downey, Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol 29, 427 (2003).
43. M. P. Fink, Role of reactive oxygen and nitrogen species in acute respiratory distress syndrome. Curr Opin Crit Care 8, 6 (2002).
44. C. M. Doerschuk, W. M. Quinlan, N. A. Doyle, D. C. Bullard, D. Vestweber, M. L. Jones, F. Takei, P. A. Ward, and A. L. Beaudet, The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 157, 4609 (1996).
45. M. Hu, Q. Du, I. Vancurova, X. Lin, E. J. Miller, H. H. Simms, and P. Wang, Proapoptotic effect of curcumin on human neutrophils: Activation of the p38 mitogen-activated protein kinase pathway. Crit Care Med 33, 2571 (2005).
46. A. Literat, F. Su, M. Norwicki, M. Durand, R. Ramanathan, C. A. Jones, P. Minoo, and K. Y. Kwong, Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 70, 253 (2001).
47. L. Cohn, J. A. Elias, and G. L. Chupp, Asthma: Mechanisms of disease persistence and progression. Annu Rev Immunol 22, 789 (2004).
48. J. A. Elias, C. G. Lee, T. Zheng, B. Ma, R. J. Homer, and Z. Zhu, New insights into the pathogenesis of asthma. J Clin Invest 111, 291 (2003).
49. B. Kay, S. Phipps, and D. S. Robinson, A role for eosinophils in airway remodelling in asthma. Trends Immunol 25, 477 (2004).
50. G. M. Walsh, M. Al-Rabia, M. G. Blaylock, D. W. Sexton, C. J. Duncan, and A. Lawrie, Control of eosinophil toxicity in the lung. Curr Drug Targets Inflamm Allergy 4, 481 (2005).
51. A. Sher, R. L. Coffman, S. Hieny, P. Scott, and A. W. Cheever, Interleukin-5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA. 87, 61 (1990).
52. T. T. Kung, D. M. Stelts, J. A. Zurcher, G. K. Adams 3rd, R. W. Egan, W. Kreutner, A. S. Watnick, H. Jones, and R. W. Chapman, Involvement of IL-5 in a murine model of allergic pulmonary inflammation, prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 13, 360 (1995).
53. M. J. Leckie, Anti-interleukin-5 monoclonal antibodies: Preclinical and clinical evidence in asthma models. Am J Respir Med 2, 245 (2003).
54. G. M. Walsh, Novel therapies for asthma: Advances and problems. Curr Pharm Des 11, 3027 (2005).
55. G. Caramori, K. Ito, and I. M. Adcock, Targeting Th2 cells in asthmatic airways. Curr Drug Targets Inflamm Allergy 3(3), 243-255 (2004).
56. M. Ichinose and P. J. Barnes, Cytokine-directed therapy in asthma. Curr Drug Targets Inflamm Allergy 3, 263 (2004).
57. J. E. Pease, Asthma, allergy and chemokines. Curr Drug Targets 7, 3 (2006).
58. T. Kobayashi, S. Hashimoto, and T. Horie, Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54, 819 (1997).
59. Y. Hu, J. Peng, D. Feng, L. Chu, X. Li, Z. Jin, Z. Lin, and Q. Zeng, Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung 84, 33 (2006).
60. Y. Moon, W. C. Glasgow, and T. E. Eling, Curcumin suppresses interleukin-1β-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharmaco. Ex. The. 315, 788 (2005).
61. C. T. Shun, S. K. Lin, C. Y. Hong, S. H. Kok, Y. H. Juan, C. C. Wang, M. C. Hsu, C. M. Liu, C.-C., Chemokine ligand 2 gene expression in nasal polyp fibroblasts, possible implication in the pathogenesis of nasal polyposis. Ann Otol Rhinol Laryngol 114, 879 (2005).
62. J. Hong, J., M. Bose, J. Ju, J. H. Ryu, X. Chen, S. Sang, M. J. Lee, and C. S. Yang, Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25, 1671 (2004).
63. Y. Abe, S. Hashimoto, and T. Horie, Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39, 41 (1999).
64. T. Yokoyama, H. Oono, A. Miyamoto, S. Ishiguro, and A. Nishio, Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats. Life Sci. 72, 1247 (2003).
65. S. K. Biswas, D. McClure, L. A. Jimenez, I. L. Megson, and I. Rahman, Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: Mechanism of free radical scavenging activity. Antioxid Redox Signal. 7, 32 (2005).
66. W. A. Wuyts, B. M. Vanaudenaerde, L. J. Dupont, M. G. Demedts, and G. M. Verleden, Involvement of p38 MAPK, JNK, p42/p44ERK and NF-κB in IL-1β-induced chemokine release in human airway smooth muscle cells. Respir Med 97, 811 (2003).
67. W. A. Wuyts, B. M. Vanaudenaerde, L. J. Dupont, D. E. Van Raemdonck, M. G. Demedts, and G. M. Verleden, Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells: Role for mitogen-activated kinases and nuclear factor-kappaB. J Heart Lung Transplant 24, 875 (2005).
68. F. Shen, X. Fan, B. Liu, X. Jia, H. Du, B. You, M. Ye, C. Huang, and X. Shi, Overexpression of cyclin D1-CDK4 in silica-induced transformed cells is due to activation of ERKs, JNKs/AP-1 pathway. Toxicol Lett 160, 185 (2006).
69. S. Chakraborty, M. Roy, and R. K. Bhattacharya, Prevention and repair of DNA damage by selected phytochemicals as measured by single cell gel electrophoresis. J Environ Pathol Toxicol Oncol 23, 215 (2004).
70. D. M. Brown, D. M., P. H. Beswick, and K. Donaldson, Induction of nuclear translocation of NF-kappaB in epithelial cells by respirable mineral fibres. J Pathol 189, 258 (1999).
71. R. P. Schins, A. McAlinden, W. MacNee, L. A. Jimenez, J. A. Ross, K. Guy, S. P. Faux, and K. Donaldson, Persistent depletion of I kappa B alpha and interleukin-8 expression in human pulmonary epithelial cells exposed to quartz particles. Toxicol Appl Pharmacol 167, 107 (2000).